Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
307.3 USD | -0.68% | -2.69% | +6.33% |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
05-22 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.33% | 166B | |
+38.39% | 723B | |
+34.28% | 595B | |
-4.58% | 369B | |
+20.20% | 332B | |
+2.28% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.24% | 168B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating